ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Rochester, MN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Overweight
Diabetic Foot
Foot Ulcer

Diabetes trials near Rochester, MN, USA:

Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes (ReCET)

This study is designed to evaluate the safety and effectiveness of endoscopic intestinal re-cellularization therapy in individuals with type 2 diabetes...

Enrolling
Diabetes
Type2diabetes
Device: ReCET Treatment
Device: Sham Procedure
Endogenex

Rochester, Minnesota, United States and 44 other locations

with teplizumab compared with placebo, both administered by intravenous (IV) infusion, in participants with recently diagnosed Stage 3 type 1 diabetes...

Enrolling
Type 1 Diabetes Mellitus
Other: Placebo
Drug: Teplizumab

Phase 3

Sanofi
Sanofi

Rochester, Minnesota, United States and 159 other locations

fenofibrate is effective for reducing the onset of proliferative diabetic retinopathy (PDR) or and the results are adopted by the community ...

Enrolling
Diabetic Retinopathy
Other: Placebo
Drug: Fenofibrate

Phase 3

Jaeb Center for Health Research
Jaeb Center for Health Research

Rochester, Minnesota, United States and 65 other locations

The study medicine will be investigated in participants with type 1 diabetes. The study will look at how well insulin icodec taken weekly co...

Enrolling
Diabetes Mellitus, Type 1
Drug: Insulin glargine
Drug: Insulin icodec

Phase 3

Novo Nordisk
Novo Nordisk

Rochester, Minnesota, United States and 183 other locations

This randomized trial will compare treatment strategies for proliferative diabetic retinopathy (PDR). Participants will receive either combi...

Enrolling
Proliferative Diabetic Retinopathy (PDR)
Drug: Faricimab
Device: Endolaser

Phase 3

Jaeb Center for Health Research
Jaeb Center for Health Research

Rochester, Minnesota, United States and 27 other locations

Recently updated

The primary objective of the FALCON study is to evaluate the efficacy of KL1333 on selected disease manifestations of primary mitochondrial disease (...

Enrolling
Primary Mitochondrial Disease
Drug: Placebo
Drug: KL1333

Phase 2

Pharming Healthcare

Rochester, Minnesota, United States and 54 other locations

This is an open-label extension study to evaluate the long-term safety of relacorilant in patients with endogenous Cushing syndrome who successfully...

Active, not recruiting
Cushing Syndrome
Drug: relacorilant

Phase 2

Corcept Therapeutics
Corcept Therapeutics

Rochester, Minnesota, United States and 47 other locations

This study is researching experimental drugs called trevogrumab and garetosmab (called "study drugs") in combination with another drug, semaglutide (...

Active, not recruiting
Obesity
Drug: Matching Placebo-Trevogrumab
Drug: Matching Placebo-Garetosmab

Phase 2

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Rochester, Minnesota, United States and 67 other locations

This Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis histological stage F2 or F3

Active, not recruiting
NASH - Nonalcoholic Steatohepatitis
Drug: Placebo
Drug: IVA337

Phase 3

Inventiva Pharma

Rochester, Minnesota, United States and 467 other locations

Semaglutide is a medicine studied in patients with NASH. Semaglutide is a well-known medicine, which is already used by doctors to treat type 2 diabetes...

Active, not recruiting
Non-alcoholic Steatohepatitis
Drug: Placebo
Drug: Semaglutide

Phase 3

Novo Nordisk
Novo Nordisk

Rochester, Minnesota, United States and 556 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems